Session 1: Autologous and allogeneic cell therapies – what’s the latest progress in reducing process timeframes and cost of goods while enhancing scalability, quality, and consistency?

Advanced Therapies Week 2027 · 19 January 2027 · 11:00–12:00 · Theatre 2

Session 1: Autologous and allogeneic cell therapies – what’s the latest progress in reducing process timeframes and cost of goods while enhancing scalability, quality, and consistency? was a session at Advanced Therapies Week 2027 on 19 January 2027 in San Diego, with 5 speakers on record.

Speakers

• Jeffrey Cram — Speaker Vice President of Process Development, Elevatebio
• Sarah Yuan — Speaker Chief Technology Officer, Cabaletta Bio
• Mamta Kalra — Speaker Vice President Process and Analytical Development, Immatics
• Isabel Tian — Speaker Senior Director, Scientific Affairs, Cellares
• Greg Russotti — Speaker Chief Technology & Manufacturing Officer, Century Therapeutics